Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The LEADER trial was an international, randomised, double-blind, controlled cardiovascular outcomes trial (CVOT)
In Ontario, if the drug is considered under the Exceptional Access Program (EAP), include a copy of the EAP approval or denial with this form
Contact a Rybelsus Vision Loss Lawyer Were you diagnosed with a vision problem such as NAION or blindness after taking Rybelsus
Additionally, a randomized controlled trial revealed that a combination of flavan-3-ols and isoflavones enhanced insulin sensitivity and lipoprotein profiles compared to placebo, further lowering the estimated 10-year CVD risk in women with type 2 diabetes (Peter et al., 2012)
US$ 27.01
US$ 28.49
US$ 22.29
US$ 28.53
US$ 28.18
US$ 24.79
US$ 27.74
US$ 26.55
US$ 23.10
US$ 21.23
